Forty years ago, an article in JAMA entitled “The Sad Truth About Hemodialysis in Diabetic Nephropathy” highlighted the poor outcomes for patients with diabetes who were treated with dialysis.1 In the early 1970s some patients with diabetes were not offered dialysis because of expected poor outcomes. The problems of visual deterioration and chronic fluid overload have been largely resolved with laser therapy for diabetic retinopathy and vastly improved dialysis techniques. In a report published in 1972, among 9 patients with renal failure resulting from diabetic nephropathy who were treated by hemodialysis, survival was 22% (2 patients) at the end of 1 year,1 whereas in 2008, data from the US Renal Data System indicate that for patients with diabetes who initiated dialysis, survival was 81% at the end of 1 year.2
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 9
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Care at the Close of Life EDUCATION GUIDESPractical Considerations in Dialysis Withdrawal
All results at
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.